Cite
HARVARD Citation
Kavanagh, S. et al. (2018). AML refractory to primary induction with Ida-FLAG has a poor clinical outcome. Leukemia research. pp. 22-28. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kavanagh, S. et al. (2018). AML refractory to primary induction with Ida-FLAG has a poor clinical outcome. Leukemia research. pp. 22-28. [Online].